000 | 01581 a2200445 4500 | ||
---|---|---|---|
005 | 20250516173258.0 | ||
264 | 0 | _c20140313 | |
008 | 201403s 0 0 spa d | ||
022 | _a2173-9110 | ||
024 | 7 |
_a10.4321/S1135-57272013000400004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonet Pla, Alvaro | |
245 | 0 | 0 |
_a[Dabigatran versus acenocumarol for the prevention of stroke in atrial fibrillation: budget impact analysis in one health department in Spain]. _h[electronic resource] |
260 |
_bRevista espanola de salud publica _c |
||
300 |
_a331-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcenocoumarol _xadministration & dosage |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
650 | 0 | 4 | _aBudgets |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aDabigatran |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 |
_aDrug Substitution _xeconomics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSpain |
650 | 0 | 4 |
_aStroke _xetiology |
650 | 0 | 4 |
_abeta-Alanine _xadministration & dosage |
700 | 1 | _aGosalbes Sóler, Victoria | |
700 | 1 | _aRidao-López, Manuel | |
700 | 1 | _aNavarro Pérez, Jorge | |
700 | 1 | _aNavarro Cubells, Blanca | |
700 | 1 | _aPeiró, Salvador | |
773 | 0 |
_tRevista espanola de salud publica _gvol. 87 _gno. 4 _gp. 331-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4321/S1135-57272013000400004 _zAvailable from publisher's website |
999 |
_c23147733 _d23147733 |